EZZ Life Science Holdings Limited (ASX:EZZ)
Australia flag Australia · Delayed Price · Currency is AUD
1.575
+0.075 (5.00%)
Apr 16, 2025, 3:31 PM AEST

EZZ Life Science Holdings Revenue

EZZ Life Science Holdings had revenue of 30.29M AUD in the half year ending December 31, 2024, with 100.24% growth. This brings the company's revenue in the last twelve months to 75.03M, up 71.65% year-over-year. In the fiscal year ending June 30, 2024, EZZ Life Science Holdings had annual revenue of 66.44M with 78.88% growth.

Revenue (ttm)
75.03M
Revenue Growth
+71.65%
P/S Ratio
0.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
70.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202466.44M29.30M78.88%
Jun 30, 202337.14M22.12M147.26%
Jun 30, 202215.02M-7.27M-32.60%
Jun 30, 202122.29M4.32M24.03%
Jun 30, 202017.97M6.78M60.62%
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings